MetLife (MET) News Today

MetLife, Inc. (MET) shares are trading lower today as a combination of softer-than-expected earnings results and analyst target cuts weigh on investor sentiment, despite continued growth in key regions and positive product recognition.

• Positive Sentiment: MetLife reported a 9% sales increase in Asia and Latin America and outlined strategic moves to capitalize on dynamic market conditions. MetLife Signals Growth in Asia & Latin America
• Positive Sentiment: MetLife Pet Insurance was named “Pet Insurance of the Year” at the 2025 Pet Innovation Awards, highlighting strong brand positioning in the fast-growing pet care market. Pet Innovation Awards Recognition
• Positive Sentiment: Growth in EMEA and Latin America helped offset weaknesses in its MetLife Holdings unit during Q2, providing some relief after an earnings miss. Q2 Earnings Relief in EMEA & Latin America
• Neutral Sentiment: Wall Street analysts remain bullish on MET’s long-term prospects, even though the stock has underperformed broader markets over the past year. Wall Street Bullish on MetLife?
• Neutral Sentiment: A recent deep dive into seven analyst ratings offers a range of perspectives on valuation and growth drivers for MET. Analyst Perspectives Deep Dive
• Neutral Sentiment: The full Q2 2025 earnings call transcript provides detailed commentary from MetLife executives and key institutional investors. Q2 2025 Earnings Call Transcript
• Negative Sentiment: UBS Group lowered its price target on MET from $94 to $91, signaling more modest upside expectations despite maintaining a “buy” rating. UBS Lowers MET Price Target
• Negative Sentiment: MetLife’s Q2 EPS fell 11% year-over-year, reflecting pressure on profitability amid a challenging interest rate environment. Q2 EPS Falls 11%
• Negative Sentiment: Q2 earnings lagged analyst estimates largely due to a soft performance at MetLife Holdings, dampening overall results. Soft MetLife Holdings Drags Q2